A Systematic Scoping Review of Psychological Therapies for Psychosis within Acute Psychiatric Inpatient Settings by Jacobsen, Pamela et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
Document Version
Peer reviewed version
Link to publication record in King's Research Portal
Citation for published version (APA):
Jacobsen, P. C., Hodkinson, K., Peters, E. R., & Chadwick, P. (2018). A Systematic Scoping Review of
Psychological Therapies for Psychosis within Acute Psychiatric Inpatient Settings. British Journal of Psychiatry.
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 14. Jun. 2018
1 
 
Title: A Systematic Scoping Review of Psychological Therapies for Psychosis within Acute 
Psychiatric Inpatient Settings 
 
Short Title:  Systematic review of acute inpatient therapies 
 
Authors:  Pamela Jacobsen1 (pamela.jacobsen@kcl.ac.uk); Kathleen Hodkinson2 
(drkhodkinson@gmail.com); Emmanuelle Peters1,3 (emmanuelle.peters@kcl.ac.uk); Paul 
Chadwick1 (paul.chadwick@kcl.ac.uk) 
1King’s College London, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), 
Department of Psychology, London, UK  
2 Webster Vienna Private University, Vienna, Austria 
3 South London and Maudsley NHS Foundation Trust, London, UK 
 
Corresponding Author: Dr. Pamela Jacobsen, Department of Psychology (PO 77), 
Institute of Psychiatry, Psychology & Neuroscience, King’s College London, SE5 8AF,  
Email: pamela.jacobsen@kcl.ac.uk 
Telephone: (00)44 2078485046 
 
Word Count (Abstract): 232 
Word Count (text body): 4184  
 
  
2 
 
A Systematic Scoping Review of Psychological Therapies for Psychosis within Acute 
Psychiatric Inpatient Settings 
 
Abstract 
 
Background: People with psychotic disorders account for most acute admissions to 
psychiatric wards.  Psychological therapies are a treatment adjunct to standard medication 
and nursing care, but the evidence base for such therapies within inpatient settings is unclear.  
Aims: To conduct a systematic scoping review of the current evidence base for psychological 
therapies for psychosis delivered within acute inpatient settings (PROSPERO: 
CRD42015025623).   
Methods: All study designs, and therapy models, were eligible for inclusion in the review.  
We searched PubMed, PsychINFO, EThOS, ProQuest, conference abstracts and trial 
registries.   
Results: We found 65 studies that met criteria for inclusion in the review, 21 of which were 
randomised controlled trials (RCTs).  The majority of studies evaluated cognitive-
behavioural interventions. Quality was variable across all study types.  The RCTs were 
mostly small (N<25 in treatment arm), and many had methodological limitations including 
poorly described randomisation methods, inadequate allocation concealment and non-blinded 
outcome assessments.  We found studies used a wide range of different outcome measures, 
and relatively few studies reported affective symptoms or recovery-based outcomes. Many 
studies described adaptations to treatment delivery within inpatient settings, including 
increased frequency of sessions, briefer interventions and use of single-session formats.  
Conclusions: Based on these findings, there is a clear need to improve methodological rigour 
within inpatient research. Interpretation of the current evidence base is challenging given the 
wide range of different therapies, outcome measures and models of delivery described in the 
literature. 
 
Declarations of interests 
 
The authors declare no competing interests. 
 
  
3 
 
Introduction 
 
Psychiatric inpatient care is a scarce and expensive resource in healthcare systems across the 
world.  Admission to hospital is usually a last resort for the most acutely unwell patients, and 
consequently the majority of inpatients have a psychosis diagnosis (1).  Patient satisfaction 
with the care they experience during an inpatient admission is generally low (2, 3).  A 
common source of dissatisfaction with acute inpatient care is the lack of access to 
psychological therapies, as an adjunct to medication (4).  Good practice guidelines for 
inpatient wards recommend access to evidence-based psychological therapies (5).  However, 
it is not clear what constitutes an evidence-based inpatient psychological therapy.  
International treatment guidelines for schizophrenia recommend Cognitive Behavioural 
Therapy for psychosis (CBTp) (6-8).  However, these recommendations are largely based on 
trials conducted in community settings.  At the time of writing the protocol for the current 
review, no systematic reviews or meta-analyses focusing solely on psychological 
interventions for psychosis within inpatient settings had been either published or registered 
on the PROSPERO database. The aim of the current paper was therefore intended mainly as a 
‘scoping’ review.  This kind of review is used to find out the potential size and scope of the 
available research literature, and may include ongoing or planned research (9).  Scoping 
reviews are particularly relevant to areas of healthcare where it is not clear whether the 
evidence exists to answer a more precise question, such as the effectiveness of a particular 
therapy within a particular setting.  The aim of this review was therefore to explore and map 
out the evidence base for psychological therapies for psychosis within acute inpatient 
settings.  
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Method 
 
A review protocol was written and registered in the public domain before searching and data 
extraction began (PROSPERO Registration:  CRD 42015025623). Five review questions 
were set in advance:- 
 
1) What is the current state of the evidence base for psychological therapies for 
psychosis within acute psychiatric inpatient settings? 
2) What study designs are used to evaluate psychological therapies for psychosis within 
acute inpatient settings? 
3) How are psychological therapies for psychosis within acute psychiatric inpatient 
settings evaluated, and what are considered to be the key outcome measures? 
4) What health care professionals are involved in delivering psychological therapies for 
psychosis, and in which roles (e.g. sole therapist, group co-facilitator, clinical 
supervisor)? 
5) How are psychological therapies for psychosis adapted for use within acute 
psychiatric inpatient settings? 
 
We included only studies published in English, with no date restrictions on searches.  
Searches were initially run in September 2015, and updated in December 2016.  We planned 
to include a wide range of different study types to address the main review question 
pertaining to the current state of the evidence base.  We anticipated that there would be 
relatively few eligible randomised controlled trials (RCTs), and the majority of studies would 
be small-scale, uncontrolled, non-randomised studies. Eligible studies therefore included 
RCTs, uncontrolled studies, observational studies, case studies, study protocols and 
qualitative studies.  We searched for studies on psychological therapies for psychotic 
symptoms within acute psychiatric inpatient care (adult wards only).  We defined inclusion 
based on the care setting, rather than solely the diagnosis of patients, on the basis that acute 
care is not diagnosis-specific in most countries, and not all patients receiving inpatient care 
may yet have an established diagnosis.  We defined acute psychiatric care as including 
triage/acute assessment wards, general acute wards and psychiatric intensive care units 
(PICU).  Non-acute inpatient care settings were excluded (e.g. rehabilitation wards, specialist 
units, residential therapy units).  Non-inpatient acute services were also excluded (e.g. day 
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hospitals, crisis/home treatment teams).  We included any psychological intervention/therapy 
aimed at alleviating distress or impairment to functioning arising from psychotic symptoms 
(e.g. voices, delusions) or aimed at emotional difficulties commonly associated with 
psychotic symptoms (e.g. anxiety, depression). This therefore excluded compliance therapy, 
and any intervention focused primarily on improving psychiatric ‘insight’.  We included 
individual, family and group therapies, delivered by any health care professional, of any 
length, frequency or duration, but not purely staff-based interventions, therapeutic 
community or milieu therapy. We included any therapies started within the acute inpatient 
setting, whether or not the therapies continued post-discharge.  We included CBT-based 
psychological therapies, broadly defined as a talking therapy based on an underlying 
theoretical model of the relationship between thoughts, emotions and behaviours. So-called 
third-wave cognitive therapies including mindfulness, acceptance and commitment therapy 
(ACT), meta-cognitive therapy (MCT), dialectical-behavioural therapy (DBT) and 
compassion-focused therapy were included and classified as sub-types of CBT. Non-CBT 
based therapies such as psychodynamic therapy were also included.  Cognitive-remediation 
therapy (CRT) was excluded on the basis that it is aimed primarily at remediating cognitive 
deficits rather than emotional difficulties associated with psychotic symptoms (likewise any 
intervention such as social skills training which is focussed primarily on the remediation of 
functioning).    Arts therapies including art, drama and movement therapy were also 
excluded.  Studies with any, or no control conditions, were included.  The search strategy and 
search terms for each resource is available in online supplementary material.   
 
Eligible studies were identified by the primary (PJ) and secondary (KH) reviewer. In the first 
stage, PJ independently screened all titles and abstracts identified from searches to determine 
which met the inclusion criteria. In the second stage, PJ and KH both independently screened 
full text articles for inclusion or exclusion, with discrepancies resolved by discussion. For 
included studies, we linked multiple reports from the same study, so that each study (rather 
than each report) was the unit of interest in the review. A standard data extraction template 
was used to record relevant information from each included study.  Data for each study were 
extracted by either PJ or KH, with each reviewer cross-checking each of the other reviewer’s 
forms to ensure consistency and accuracy of data extraction.  In keeping with the range of 
this ‘scoping’ review, the quality of eligible studies was assessed using the Mixed Methods 
Appraisal Tool (MMAT; Pluye (10)). The MMAT is designed to assess quantitative, 
qualitative and mixed methods studies using a single integrated tool.  The initial stage 
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involved assessing each study according to two standard screening questions (is there a clear 
research question, and do the data collected address this question).  Further assessment with 
the MMAT was not feasible or appropriate for studies which failed the screening questions, 
or which did not report any outcomes (whether quantitative or qualitative).  The second stage 
involved assessment under 1 of 5 categories, depending on the type of study, each with 4 
assessment criteria.  A summary score was calculated by dividing the number of criteria 
definitely met (i.e. scored as a ‘yes’) divided by 4, and expressed as a percentage.  Quality 
scores therefore ranged from 0%, 25%, 50%, 75% to 100%.  We additionally assessed the 
RCTs using the Cochrane Risk of Bias criteria (11).  
 
Results 
 
As shown in Figure 1, we identified 65 studies for inclusion in the review.  We used the 
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines 
in summarising the search results (12).  Fourteen of the 65 studies were linked to at least one 
other record (e.g. Drury et al (13) was published as 3 peer-reviewed journal articles as well as 
a PhD thesis).  In this case, where at least one of the records was a peer-reviewed journal 
article, this was taken as the ‘primary’ reference.  In the case of RCTs, which often published 
acute-phase and follow-up data in separate journal articles, the paper that had been published 
first was designated as the primary paper.  However, the data extraction form was completed 
using all relevant information across all linked studies. Overall, 58 out of the 65 studies had a 
peer-reviewed journal article designated as the primary paper.  Of the remaining studies, 4 
were published solely as book chapters, 1 was published as a PhD thesis and we could not 
find any subsequent published journal articles (14)  and the remaining 2 existed only as trial 
registry records - one of these had not yet been published in a peer-reviewed journal because 
the trial was still on-going (15), and the other reported results on the trial registry website but 
we could find no evidence of subsequent publication in a peer-reviewed  journal (16).  
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Figure 1: PRISMA Flowchart 
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Figure 1:  PRISMA Flowchart 
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Review Question 1: Current state of evidence base 
 
Sixty-five studies were included in the review (see online supplementary material).  Overall, 
40% of studies failed the initial MMAT screening stage (26/65).  Of the remaining 60% 
which were assessed further, 21.5% were rated as high quality, 20% were medium quality 
and 18.5% were low-quality.  We broadly categorised therapies into CBT, and non-CBT 
models, with sub-types of therapy noted where appropriate.  Overall, we found there were 
slightly more CBT studies (N=35) than non-CBT therapies (N=28).  We took a broad 
definition of therapy models, but even so were unable to categorise two studies into a 
recognisable therapy model (Dichos therapy (17) & Computer-facilitated therapy (18)).  
Among the CBT studies, there was a noticeable increase in so-called third wave cognitive 
therapies in recent years, with 12 studies categorised as either mindfulness, compassion-
focused, or acceptance and commitment therapy (ACT).  The majority of the non-CBT 
studies were psychodynamic (N=17).  A clear difference emerged between countries in their 
dominant therapy models.  For the UK studies, over 75% were CBT based (16/20). However, 
the reverse was true for the USA studies, with 62% of studies being non-CBT based (16/26).  
For other countries (which were predominantly European), CBT and non-CBT studies were 
more evenly balanced (11 CBT and 8 non-CBT).  The first CBT studies did not emerge until 
the 1980s, but they represent the majority of studies included in the review published since 
2000.   
 
In order to provide a broad overview of the main findings of the studies in the review, 
relevant studies were identified according to four criteria.  These were 1) the stated aim of the 
study was described as evaluating efficacy/effectiveness 2) the study reported at least one 
outcome measure 3) the study stated which was the primary outcome measure, where 
multiple outcomes were reported and 4) the study passed MMAT screening stage.  Twelve 
studies in total met all these criteria and are summarised in Table 1, in chronological order. 
No exclusions were made based on study quality, therefore the findings should be interpreted 
with appropriate caution, and in the context of the associated MMAT quality scores (see 
online supplementary material).   
  
9 
 
Table 1 Summary of main findings (efficacy studies with primary outcomes only) 
Author 
(year) 
 
Study Design 
 
Country 
Treatment 
 
 
n=no. of participants 
Control condition(s) 
 
 
n=no. of participants 
Primary Outcome 
Measure 
Main Findings 
Bookhammer et al 
(1966) 
 
Non-randomised 
Controlled Trial 
 
USA 
Rosen’s Direct 
Analysis 
 
n=14 
Treatment as Usual 
(TAU) 
 
n=37 
Binary outcome of 
improved/unimproved 
as rated by treating 
clinician at 5 year 
follow-up 
No difference in rates 
of improvement 
between the Direct 
Analysis and TAU 
groups  
Serok and Zemet 
(1983) 
 
Non-randomised 
Controlled Trial 
 
Israel 
Gestalt group therapy 
 
 
n=16 
Treatment as usual 
(TAU) 
 
n=15 
Neuropsychological 
reality perception test 
Gestalt group showed 
evidence of 
improvement in 
perception of self and 
others 
Beutler 
(1984) 
 
Randomised 
Controlled Trial 
 
USA 
1) Behavioural/task 
(BT) 
2) Expressive-
experiential (EE) 
3) Process-oriented 
(PO) 
 
Number of 
participants in each 
group not stated 
(Total n=176 
including controls) 
Treatment as usual 
(TAU) 
Composite symptom 
measure (including 
symptom check-list, 
nurse assessment, and 
group facilitator 
ratings) 
Compared to TAU 
group:- 
1) no change in BT 
group, 2) 
deterioration in EE 
group 
3) improvement in 
PO group 
Cholet 
(1984) 
 
Randomised 
Controlled Trial 
 
USA 
Humanistic-
existential (HE) 
psychotherapy  
 
 
n=20 
Equivalent time as in 
treatment condition 
spent with college 
student  
 
n=20 
Behavioural 
adjustment scale 
(staff rated) 
No difference 
between groups on 
mood, co-operation 
or communication 
sub-scale but 
significant 
improvement on 
social contact scale in 
HE group compared 
to control  
Cole and Greene 
(1988) 
 
Service Evaluation 
 
USA 
Unstructured 
psychodynamic 
group 
 
n=20 (repeated 
measures design –all 
patients did both 
groups) 
Structured 
occupational therapy 
group 
 
n=20 (repeated 
measures design –all 
patients did both 
groups) 
Patient self-report of 
which group they 
preferred 
Patients preferred the 
occupational therapy 
group to the 
psychodynamic 
group 
Bach and Hayes 
(2002) 
 
Randomised 
Controlled Trial 
 
USA 
Acceptance and 
Commitment 
Therapy (ACT) 
 
n=40 
Enhanced Treatment 
as Usual (ETAU) 
 
 
n=40 
Re-admission to 
hospital at 4-month 
post-discharge 
Re-admission to 
hospital was 
significantly lower in 
the ACT group 
(20%) compared to 
the ETAU group 
(40%) 
Hauff et al (2002) 
 
Non-randomised 
Controlled Trial 
 
 
Norway 
Specialist therapy 
ward with individual 
psychotherapy + 
psychodynamic 
milieu 
 
n=25 
Standard care on 
acute ward 
 
 
 
 
n=71 
Global mental health 
status at 7 year 
follow-up 
No difference 
between outcomes 
for patients treated on 
the specialist therapy 
ward compared to the 
standard care ward 
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Lewis et al 
(2002) 
 
Randomised 
Controlled Trial  
 
UK 
Cognitive-behaviour 
therapy (CBT) 
 
n=101 
Supportive 
counselling  
 
n=106 
 
Treatment as usual 
(TAU) 
 
n=102 
Psychotic symptoms 
at 70 day follow-up 
All patients improved 
significantly over 
time, with a trend to 
faster improvement 
in the CBT group 
Startup et al 
(2004) 
 
Randomised 
Controlled Trial 
 
UK 
Cognitive-behaviour 
therapy (CBT) 
 
n=47 
Treatment as usual 
(TAU) 
 
n=43 
Psychotic symptoms 
at 12 month follow-
up 
The CBT group 
showed significantly 
greater improvement 
compared to the TAU 
group 
Veltro et al 
(2006) 
 
Non-randomised 
Controlled Trial 
 
 
Italy 
Cognitive-behaviour 
group therapy (CBT) 
as part of ward 
routine care 
 
n=352 
Ward routine care 
before introduction of 
CBT programme 
(pre-post design) 
 
n=150 
Total re-admissions 
up to 4 year follow-up 
The re-admission rate 
was significantly 
lower in the 4 years 
following the 
introduction of CBT 
(24%) compared to 
the year before its 
introduction (38%) 
Klingberg et al 
(2010) 
 
Randomised 
Controlled Trial 
 
Germany 
Cognitive 
Behaviorally 
Oriented Service 
(CBOS) – individual, 
group and family 
sessions  
 
 
n=84 
Individual supportive 
treatment – 
individual and group 
sessions based on 
practical and non-
directive emotional 
support 
 
n=85 
Mean time to relapse 
(defined by 
deterioration on 
psychotic symptom 
rating scale) 
Mean time to relapse 
was significantly 
longer in the CBOS 
group (168 days) 
compared to the 
control group (157 
days) 
Moritz et al 
(2011) 
 
Randomised 
Controlled Trial 
 
Germany 
Meta-Cognitive 
Therapy (MCT) 
 
 
 
n=24 
Cogpak 
(computerised 
cognitive remediation 
therapy) 
 
n=24 
Delusions severity at 
end of treatment 
Significantly greater 
decline in delusion 
severity in the MCT 
group compared to 
control group 
 
 
Review Question 2: Types of study design (including quality assessment) 
 
As expected, a full range of study designs were included in the review, from single case 
studies to large-scale RCTs.  RCTS were more likely to describe CBT, rather than non-CBT 
interventions, and the converse was true for non-randomised controlled trials.  Service 
evaluation, case series/studies and qualitative studies were more evenly matched between 
CBT and non-CBT models.  Quality assessment scores were variable across different 
categories of study designs.  For the RCTs (N=21), there was evidence of an improvement in 
quality over time, as all studies published pre-2000 were rated as low-medium quality (0-
50%), but post-2000 included at least 5 studies rated as high quality (75-100%).  This 
probably reflects improvements in trial reporting guidelines arising from the first publication 
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of the CONSORT statement in the 1990s (19), and its subsequent adoption by most major 
journals.   
 
In addition to the MMAT, we also assessed RCTs using the Cochrane Risk of Bias (see 
online supplementary material).  Overall, the risk of bias was lower for attrition and reporting 
bias, with most RCTs reporting <20% loss to follow-up at trial end-point, and appropriately 
reporting pre-specified trial outcomes.  However, randomisation methods, allocation 
concealment and blinding were causes for concern (Figure 2).    Only two of the RCTs clearly 
stated using the ‘gold standard’ of an independent randomisation service with randomly 
varying block sizes, with a large number of studies not specifying the randomisation method 
at all (N=10).  A minority of studies mentioned blinding of outcome assessors, and blinding 
of the inpatient and/or community teams potentially involved in treatment decisions.  Size of 
trials was also a concern – out of the 19 RCTs with published results, over half (N=10) had 
fewer than 25 people in the treatment arm.  Finally, most of the RCTs used TAU (or 
‘enhanced’ TAU in the Gaudiano trials) as the control arm (N=11), and therefore did not 
control for non-specific therapy factors such as time and attention from a warm, empathic 
therapist.  A minority of trials did use an active control arm.  One of the largest trials had a 
strong design in this respect, and included both a supportive counselling and TAU condition, 
with over 100 participants in each arm (20). 
 
  
Figure 2 Risk of Bias Summary for RCTs presented as percentages across included studies (N=19) 
  
Random sequence allocation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias)
Blinding of outcome assessment (detection bias)
Incomplete outcome data (attrition bias)
Selective reporting (reporting bias)
Other bias
Low risk of bias Unclear risk of bias High risk of bias
0% 25% 50% 75% 100%
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Review Question 3: Evaluation and Outcome measures 
 
Most of the studies included in the review reported collecting some kind of outcome measure 
(N=48).  We categorised the outcome measures used into four main categories (psychotic 
symptoms, affective symptoms, general/clinical functioning, and readmission/relapse).  The 
results are summarised in Table 2.  Where outcome measures were reported, these were 
usually focused on assessing psychotic symptoms and/or general functioning.  There were 
relatively few studies that reported assessing affective symptoms, such as depression or 
anxiety.  Only 3 of the 65 studies used self-report recovery measures.  Even though they were 
not usually the primary outcome measure, many studies reported readmission/relapse data.  
The timing of outcome assessments was variable, and usually included a combination of 
different time points (e.g. baseline, discharge and 6-month follow-up).  The assessment 
schedule was not specified in two studies.  For the remaining studies 46 studies, 32 reported 
data at baseline, 12 reported outcomes session-by-session, 4 at mid-therapy and 26 at 
discharge/end of therapy.  Twenty-one studies reported follow-up data beyond the end of 
therapy.  The longest follow-up point was 6 months or less for 10 studies, and longer than 6 
months for the remaining 11 studies. 
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Table 2 Summary of outcome measures for studies reporting any kind of outcome (N=48) 
 INCLUDED? 
DOMAIN 
(No. of studies including each scale in 
parentheses) 1 
 
N=48 studies (21 RCTs)  
 
Yes (RCTs 
only) 
 
No (RCTs only) 
 
1) Psychotic symptoms 
 
- UNPUBLISHED SCALES (4) 
- PANSS (7) 
- PSYRATS (5) 
- BPRS (5) 
- PAS (2) 
- SAPS/SANS (2) 
- SAHI (1) 
21 (16) 27 (5) 
2) Affective symptoms 
 
- UNPUBLISHED SCALES (3) 
- BAI/BDI (2) 
- HADS (1) 
- DASS (1) 
- HDI (1) 
7 (2) 41 (19) 
3) General/Clinical 
Functioning 
 
- GAF (3) 
- HSRS (1) 
- GAS (3) 
- ADL (1) 
- CORE (34 OR 10 ITEM) (2) 
- CGI-S (1) 
- SFS (3) 
- NOISE (1) 
- OQ-45 (1) 
14 (7) 34 (14) 
4) Recovery 
 
- Self-rating of goals (1) 
- MHCS (2) 
- QPR (1) 
3 (1) 45 (20) 
5) Readmission 
           
    Relapse (defined other than just 
readmission e.g. exacerbation in 
symptoms) 
13 (10) 
 
6 (4) 
35 (11) 
 
42(17) 
  
                                                 
1 Some studies included more than 1 scale within the same domain 
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Key to abbreviations: PANSS=Positive and Negative Syndrome Scale (21); PSYRATS= Psychotic Symptom Rating 
Scales (22); BPRS=Brief Psychiatric Rating Scale (23); PAS=Psychiatric Assessment Scale (24); SAPS=Scale for the 
Assessment of Positive Symptoms (25); SANS=Scale for the Assessment of Negative Symptoms (26); SAHI=Structured 
Auditory Hallucinations Interview (27); BDI=Beck Depression Inventory (28); BAI=Beck Anxiety Inventory (29); 
HADS=Hospital and Anxiety Depression Scale (30); DASS=Depression, Anxiety & Stress Scales (31); HDI=Hamilton 
Depression Inventory (32); GAF=Global Assessment of Functioning (33); HSRS=Health Sickness Rating Scale (34); 
GAS=Global Assessment Scale (35); ADL=Activities of Daily Living; CORE=Clinical Outcomes in Routine 
Evaluation(36); CGI-S=Clinical Global Impression Scale (37); SFS=Social Functioning Scale (38); NOISE=Nurses’ 
Observation Scale for Inpatient Evaluation (39); OQ-45=Outcome Questionnaire-45 (40); MHCS=Mental Health 
Confidence Scale (41); QPR=Questionnaire about the Process of Recovery (42) 
 
Review Question 4: Delivery of therapies 
 
The most common mode of delivery was group therapy (N=27), followed by individual 
therapy (N=19).  There was a notable difference in the types of trial design between group 
and individual treatment modalities.  The majority of the studies describing individual 
therapies were RCTs (12/19), compared to 3/27 of the group therapy studies.   
As anticipated, a variety of staff groups were involved with delivering psychological 
therapies within inpatient settings, including psychologists, psychiatrists, nurses, occupational 
therapists, social workers, family therapists, CBT therapists and clinical trainees from 
different disciplines.   It was notable however that almost a third of the studies included in the 
review failed to specify the professional group delivering the intervention.  This limits the 
interpretation and replicability of such studies.  The primary, or sole, therapist was described 
as a Clinical Psychologist in the majority of studies where the profession was specified 
(N=14).   
 
Training, supervision and checks on treatment fidelity were generally poorly described or 
entirely absent.  Over 50% of studies included in the review gave no details about training 
and supervision of therapists.  For the 21 RCTs in the review, only a third of studies (N=7) 
clearly reported that the staff delivering the intervention were both trained and supervised.  
An additional third reported either staff training or supervision, but not both.  The final third 
gave no details on either.  The majority of RCTs gave no details on checking treatment 
fidelity.  Only eight studies reported fidelity checks – this was usually done by an 
independent rater reviewing a sample of audiotapes of therapy sessions (N=6), but the use of 
direct observation (N=1) and videotapes (N=1) was also reported.  
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Review Question 5: Adaptations to facilitate delivery within acute settings 
 
After an initial review of the included studies, we identified and categorised studies according 
to five main adaptations.  These were 1) increased frequency of sessions (≥2 sessions a 
week), 2) briefer interventions (≤5 sessions), 3) shorter sessions (<50 minute standard length 
of sessions), 4) use of single session format (i.e. each session is stand-alone, although therapy 
may include more than one session) and 5) continuing therapy post-discharge.  The most 
common adaptation was an increased frequency of sessions. An increased frequency of 
sessions sometimes reflected an attempt to deliver a larger number of sessions within a 
shorter period of time to fit the typical length of an inpatient admission.  Other studies aimed 
to deliver a smaller number of sessions, but still had an increased frequency of sessions to fit 
in with short lengths of admissions (43, 44).  Only a quarter of studies reported briefer 
interventions (15/65), with 5 or fewer planned sessions.  This is perhaps surprising given 
concerns that acute admissions are short, and so there is limited time to provide psychological 
therapies.  However, the number of planned sessions, or the average number of sessions 
delivered per patient, was often not stated, and we were unable to extract this information for 
many studies.  We found that the use of the standard therapy ‘hour’ (i.e. around 50 minutes) 
was in fact the most commonly reported length of session (41/65).  Over a third of studies 
reported using a single-session format (24/65).  This may be particularly helpful in settings 
when length of admission is unpredictable, and discharges may occur unexpectedly in the 
middle of treatment.  Single-session formats may be particularly useful in groups, in meeting 
the needs of people who may attend only 1 session, but also in allowing people to flexibly 
‘drop in’ over the course of an admission.  In relation to group interventions, the use of 
single-session formats is of course closely linked to whether the group is open (people can 
join and leave at any session) or closed (people can join only at the beginning and are 
encouraged to stay for the full course).  We found that open groups were the most common 
format reported (N=17), with only two studies explicitly reporting a closed group format (45, 
46).  It was not always clear whether group formats were open or closed.  There was some 
reference to continuing therapy post-discharge in 13 studies.  This was sometimes to allow 
people to complete a set number of sessions, for a group (47) or individual intervention (43).  
Some studies offered booster sessions post-discharge, but take-up of these was generally low. 
(20, 48) 
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Discussion 
 
We conducted a systematic scoping review of psychological therapies for psychosis within 
acute inpatient settings. We found that there were a broad range of therapies in the published 
literature, delivered in many different ways, by different groups of professionals, and 
evaluated using a wide range of approaches.  This makes a coherent synthesis of current 
evidence challenging.  Quality was varied across different study types and over time, but we 
found significant methodological weaknesses in many studies, including in RCTs. Such a 
high degree of heterogeneity surely provides a challenge to any quantitative synthesis of 
findings by means of a meta-analysis. Reporting of diagnosis or symptom profile is also 
inconsistent in the literature – and indeed, in practice often there is no clear diagnosis for 
inpatients. For this reason the present review took the pragmatic step of selecting studies on 
the basis of setting (acute inpatient) and type of psychological therapy (e.g. CBT for 
psychosis). We would recommend all future inpatient research on psychological therapy for 
psychosis report diagnostic information on participants where available, in addition to 
symptom profiles using established assessment tools. 
 
Evaluating therapies within inpatient settings is undoubtedly challenging. It is not possible, or 
indeed ethical, to control or keep constant all other elements of treatment each person is 
receiving, such as medication, nursing care or occupational therapy.  Attributing change, 
whether it be improvement or deterioration, to any single component of treatment is therefore 
not normally possible.  There is also the problem of accounting for ‘natural’ recovery after a 
mental health crisis. The added value of any psychological intervention should therefore 
always be carefully assessed.  
 
Outcome assessment  
 
The present study focussed on patient outcomes – as opposed for example to change in ward 
milieu or in staff well-being. Direct patient outcomes can relate to well-being during 
admission (e.g. psychotic symptoms, length of admission), or after (e.g. subsequent relapse or 
readmission rates), or both. The studies reviewed included a wide range of primary and 
secondary outcomes and assessment tools, making it difficult to draw conclusions. The field 
may therefore benefit from the development of an agreed standardised set of outcomes, 
known as ‘core outcome sets’ (COS).  A COS can be used as the minimum to be reported for 
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any study or trial, and makes it easier to combine and compare the results of studies, over 
time, and from different countries.  The urgent need for a COS in psychosis can be no better 
demonstrated than by the findings of a recent review of schizophrenia intervention trials 
(both drug and psychological therapy trials) which found 2194 different scales were used to 
measure outcomes, with every fifth study introducing a new rating instrument (49). We 
would encourage development of COS for inpatient research that address core outcomes both 
during and post admission.  
 
Therapy delivery 
 
Only 3/27 evaluations of group therapies used an RCT design, which may reflect 
methodological challenges in evaluating inpatient groups – in-patient group therapies are 
normally open to everyone on a ward, for ethical and practical reasons, and there is also 
increased risk of treatment “contamination” between conditions on inpatient wards where 
patients are in close proximity. One potential solution is to use a cluster randomised design, 
where individual wards are randomised to a particular intervention, rather than individual 
patients, although there are often important differences between wards (e.g. catchment area, 
therapeutic milieu) and larger sample sizes are needed, which is often a barrier to conducting 
this kind of study in routine clinical practice. (50)   
 
Adapting therapy protocols for in-patient settings.  
 
The majority of studies reported having adapted psychological therapy for delivery within 
inpatient settings. Commonly this meant offering traditional numbers of sessions but more 
frequently, or offering fewer sessions, or developing a single-session format. We would 
recommend that future research describe more clearly the process of adapting therapies and 
protocols: for example, giving a clear rationale for the need to adapt a therapy; a clear 
rationale for the chosen adaptations; a clear statement about if and how the adaptations were 
piloted (e.g. a small case series); being clear about the degree of service user consultation and 
participation throughout the process. Furthermore, future research might examine, perhaps 
through mixed methods, the impact of the specific adaptations made. 
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Strengths and limitations 
 
As this review was planned as a scoping review, we designed the strategy accordingly, and 
published our search strategy and review questions in advance on the PROSPERO database.   
A particular strength of this review is that we searched for literature from a wide variety of 
sources, including those not readily available (e.g. non-digitised book chapters, unpublished 
PhD theses).  However, work not published in academic journals has not been subject to the 
same degree of peer review or scrutiny, and therefore should be interpreted with caution.  We 
also attempted to search for studies underway as well as completed, by searching trial 
registries for planned or ongoing research, and by contacting experts in the field.  However, 
despite increasing calls for all trials to be pre-registered on a public registry, compliance is 
still variable.  Therefore, we cannot exclude the possibility that there is work underway that 
we would not have found from registry searches.  There were some challenges in defining 
acute care for the purposes of this review, as care settings vary from country to country, and 
over time within the same country.  We therefore adopted a liberal definition of acute care, 
and erred on the side of being over-, rather than under-inclusive.  In circumstances where the 
care setting was unclear, or did not easily fit into standard categories of inpatient care, we 
focused on assessing the eligibility of the intervention itself, and included interventions that 
seemed feasible to deliver within an average 30-day admission.  However, difficulties in 
defining key terms in the search strategy may have led to relevant studies being excluded, or 
less relevant studies being included in the final review.  
 
Conclusions and implications for practice 
 
As this was a scoping review rather than a formal attempt to synthesise efficacy data, we 
cannot draw any firm conclusions in terms of what psychological interventions are most 
efficacious within acute inpatient settings.  However, from the efficacy studies summarised in 
Table 1 there appears to be some promising evidence for the role of CBT-based approaches 
in reducing psychotic symptoms and reducing risk of relapse over the short-term.  A 
systematic approach is now clearly needed to develop the evidence base for inpatient 
psychological interventions, and to progress from promising pilot studies to larger, well-
designed RCTs in line with guidelines for developing complex interventions (51). The nature 
of inpatient care has undoubtedly changed over the 60+ years covered by this review; for 
example, in UK settings, there has been a move towards shorter acute admissions and an 
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increasing proportion of involuntary admissions (1).  This not only poses new challenges for 
inpatient therapies in terms of developing briefer interventions, which can be effectively 
integrated within a larger care pathway, including community and crisis services, but also 
highlights opportunities for acute care to be a time to engage patients in psychological 
therapies which may outlast the admission.  Qualitative research (including pre-trial 
assessment) also has a role to play, for example in optimising use of interventions within 
RCTs and in informing future choice of interventions (52). Core outcome sets are required to 
establish common, minimum outcomes both during and post admission, and the process of 
adapting therapies for in-patient settings needs greater methodological rigour and clarity.   
 
 
Contributors 
 
All authors contributed to the design of the review protocol.  PJ designed the literature 
search.  PJ and KH reviewed abstracts, selected studies for inclusion, and extracted data.  PJ 
wrote the review, and all authors read and approved the final manuscript. 
 
Acknowledgments 
 
This paper presents independent research funded by the National Institute for Health 
Research (NIHR).  Dr. Pamela Jacobsen is supported by a NIHR Doctoral Research 
Fellowship (DRF-2014-07-003).  The views expressed are those of the authors and not 
necessarily those of the NHS, the NIHR or the Department of Health. 
 
Research Ethics 
 
Ethical approval not required. 
  
20 
 
References 
 
1. NHS Benchmarking Network. Work Programme Report 2016/17.  
2. Csipke E, Flach C, McCrone P, Rose D, Tilley J, Wykes T, et al. Inpatient care 
50 years after the process of deinstitutionalisation. Soc Psych Psych Epid. 2014; 49(4): 665-
71. 
3. Csipke E, Williams P, Rose D, Koeser L, McCrone P, Wykes T, et al. Following the 
Francis report: investigating patient experience of mental health in-patient care. The British 
Journal of Psychiatry. 2016; 209(1): 35-9. 
4. Wood L, Alsawy S. Patient experiences of psychiatric inpatient care: a systematic 
review of qualitative evidence. Journal of Psychiatric Intensive Care. 2016; 12(1): 35-43. 
5. RCPsych. AIMS-AT:  Accreditation for inpatient mental health services - Standards 
for assessment/triage services.  2014. 
6. NICE. Psychosis and schizophrenia in adults: prevention and management 2014. 
7. Galletly C, Castle D, Dark F, Humberstone V, Jablensky A, Killackey E, et al. Royal 
Australian and New Zealand College of Psychiatrists clinical practice guidelines for the 
management of schizophrenia and related disorders. Australian & New Zealand Journal of 
Psychiatry. 2016; 50(5): 410-72. 
8. Dixon LB, Dickerson F, Bellack AS, Bennett M, Dickinson D, Goldberg RW, et al. 
The 2009 schizophrenia PORT psychosocial treatment recommendations and summary 
statements. Schizophr Bull. 2010; 36(1): 48-70. 
9. Grant MJ, Booth A. A typology of reviews: an analysis of 14 review types and 
associated methodologies. Health Information & Libraries Journal. 2009; 26(2): 91-108. 
10. Pluye P. Critical appraisal tools for assessing the methodological quality of 
qualitative, quantitative and mixed methods studies included in systematic mixed studies 
reviews. Journal of evaluation in clinical practice. 2013; 19(4): 722. 
11. Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The 
Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011; 343. 
12. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic 
reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339. 
13. Drury V, Birchwood M, Cochrane R, MacMillan F. Cognitive therapy and recovery 
from acute psychosis: A controlled trial: II. Impact on recovery time. The British Journal of 
Psychiatry. 1996; 169(5): 602-7. 
14. Cholet ME. Outcome of humanistic-existential therapy on inpatient and hospital 
discharged schizophrenics. Dissertation Abstracts International. 1984; 44(9-B): 2889-90. 
15. Gaudiano BA. Researching the Effectiveness of Acceptance-Based Coping During 
Hospitalization (REACH). 2015. 
16. Boden MT. Acceptance and Commitment Therapy for the Inpatient Treatment of 
Psychosis (ACT-IP). 2013. 
17. Aviera A. "Dichos" therapy group: A therapeutic use of Spanish language proverbs 
with hospitalized Spanish-speaking psychiatric patients. Cultural Diversity and Mental 
Health. 1996; 2(2): 73-87. 
18. Ahmed M, Bayog F, Boisvert CM. Computer-facilitated therapy for inpatients with 
schizophrenia. Psychiatr Serv. 1997; 48(10): 1334-5. 
19. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the 
quality of reporting of randomized controlled trials. The CONSORT statement. Jama. 1996; 
276. 
21 
 
20. Lewis S, Tarrier N, Haddock G, Bentall R, Kinderman P, Kingdon D, et al. 
Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-
phase outcomes. Brit J Psychiat. 2002; 181: S91-S7. 
21. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) 
for Schizophrenia. Schizophrenia Bulletin. 1987; 13(2): 261-76. 
22. Haddock G, McCarron J, Tarrier N, Faragher E. Scales to measure dimensions of 
hallucinations and delusions: the psychotic symptom rating scales (PSYRATS). Psychol 
Med. 1999; 29. 
23. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962; 10: 
799-812. 
24. Krawiecka M, Goldberg D, Vaughan M. A standardized psychiatric assessment scale 
for rating chronic psychotic patients. Acta Psychiatr Scand. 1977; 55(4): 299-308. 
25. Andreasen NC. Scale for the Assessment of Positive Symptoms (SAPS). University 
of Iowa, 1984. 
26. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). University 
of Iowa, 1984. 
27. Kent G, Wahass S. The content and characteristics of auditory hallucinations in Saudi 
Arabia and the UK: a cross-cultural comparison. Acta Psychiatr Scand. 1996; 94(6): 433-7. 
28. Beck AT, Steer RA, Brown GK. Beck Depression Inventory (2nd edition). The 
Psychological Corporation, 1996. 
29. Beck AT, Steer RA. Beck Anxiety Inventory Manual. Psychological Corporation, 
1993. 
30. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr 
Scand. 1983; 67(6): 361-70. 
31. Lovibond PF, Lovibond SH. Manual for the Depression Anxiety Stress Scales. 
Psychology Foundation, 1995. 
32. Reynolds WM, Kobak k. Hamilton Depression Inventory:  A self-report version of the 
Hamilton Depression Rating Scale (Manual). Psychological Assessment Resources, 1995. 
33. APA APA. Diagnostic and Statistical Manual of Mental Disorders. APA, 1994. 
34. Luborsky L, Bachrach H. Factors influencing clinicians judgments of mental health: 
Eighteen experiences with the health-sickness rating scale. Arch Gen Psychiat. 1974; 31(3): 
292-9. 
35. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure 
for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976; 33(6): 
766-71. 
36. Evans C, J M-C, Margison F, Barkham M, Audin K, Connell J, et al. CORE: Clinical 
Outcomes in Routine Evaluation. J Ment Health. 2000; 9(3): 247-55. 
37. NIMH NIoMH. Clinical Global Impressions Scale. Psychopharmacol Bull. 1985; 21: 
839-43. 
38. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The Social Functioning 
Scale. The development and validation of a new scale of social adjustment for use in family 
intervention programmes with schizophrenic patients. The British journal of psychiatry : the 
journal of mental science. 1990; 157: 853-9. 
39. Honigfeld G, Klett CJ. The Nurses' Observation Scale for Inpatient Evaluation: A 
New Scale for Measuring Improvement in Chronic Schizophrenia. J Clin Psychol. 1965; 21: 
65-71. 
40. Lambert MJ, Burlingame GM, Umphress V, Hansen NB, Vermeersch DA, Clouse 
GC, et al. The Reliability and Validity of the Outcome Questionnaire. Clinical Psychology & 
Psychotherapy. 1996; 3(4): 249-58. 
22 
 
41. Carpinello SE, Knight EL, Markowitz FE, Pease EA. The Development of the Mental 
Health Confidence Scale: A Measure of Self-Efficacy in Individuals Diagnosed with Mental 
Disorders. Psychiatric Rehabilitation Journal Winter. 2000; 23(3): 236-43. 
42. Neil ST, Kilbride M, Pitt L, Nothard S, Welford M, Sellwood W, et al. The 
questionnaire about the process of recovery (QPR): A measurement tool developed in 
collaboration with service users. Psychosis. 2009; 1(2): 145-55. 
43. Bach P, Hayes SC. The use of acceptance and commitment therapy to prevent the 
rehospitalization of psychotic patients: A randomized controlled trial. J Consult Clin Psych. 
2002; 70(5): 1129-39. 
44. Gaudiano BA, Herbert JD. Acute treatment of inpatients with psychotic symptoms 
using Acceptance and Commitment Therapy: Pilot results. Behaviour Research and Therapy. 
2006; 44(3): 415-37. 
45. Cooper P. Using Writing as Therapy: Finding identity. The British Journal of 
Occupational Therapy. 2014; 77(12): 619-22. 
46. Owen M, Sellwood W, Kan S, Murray J, Sarsam M. Group CBT for psychosis: A 
longitudinal, controlled trial with inpatients. Behaviour Research and Therapy. 2015; 65: 76-
85. 
47. Bechdolf A, Knost B, Kuntermann C, Schiller S, Klosterkötter J, Hambrecht M, et al. 
A randomized comparison of group cognitive-behavioural therapy and group 
psychoeducation in patients with schizophrenia. Acta Psychiat Scand. 2004; 110(1): 21-8. 
48. Haddock G, Tarrier N, Morrison A, Hopkins R, Drake R, Lewis S. A pilot study 
evaluating the effectiveness of individual inpatient cognitive-behavioural therapy in early 
psychosis. Soc Psych Psych Epid. 1999; 34(5): 254-8. 
49. Miyar J, Adams CE. Content and Quality of 10 000 Controlled Trials in 
Schizophrenia Over 60 Years. Schizophrenia Bulletin. 2013; 39(1): 226-9. 
50. Torgerson DJ. Contamination in trials: is cluster randomisation the answer? BMJ. 
2001; 322(7282): 355-7. 
51. MRC. Developing and evaluating complex interventions: new guidance. 2006. 
52. O’Cathain A, Thomas KJ, Drabble SJ, Rudolph A, Hewison J. What can qualitative 
research do for randomised controlled trials? A systematic mapping review. BMJ Open. 
2013; 3. 
 
23 
 
 
Section/topic  # Checklist item  
Reported on 
page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  2 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility 
criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions 
and implications of key findings; systematic review registration number.  
2 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  3 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
3 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, 
provide registration information including registration number.  
4 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years 
considered, language, publication status) used as criteria for eligibility, giving rationale.  
4 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
4 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
Supplementary 
material 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if 
applicable, included in the meta-analysis).  
4-5 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any 
processes for obtaining and confirming data from investigators.  
5 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions 
and simplifications made.  
5 
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Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this 
was done at the study or outcome level), and how this information is to be used in any data synthesis.  
11 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  N/A 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of 
consistency (e.g., I2) for each meta-analysis.  
N/A 
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Section/topic  # Checklist item  
Reported on 
page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
11 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
N/A 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for 
exclusions at each stage, ideally with a flow diagram.  
7 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) 
and provide the citations.  
Supplementary 
material 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  11 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
N/A 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  N/A 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  11 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 
16]).  
N/A 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their 
relevance to key groups (e.g., healthcare providers, users, and policy makers).  
16 
25 
 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval 
of identified research, reporting bias).  
18 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future 
research.  
18 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders 
for the systematic review.  
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Online Supplementary Material 
 
Search Terms 
Category Database/resource 
searched 
Search Terms 
1. Electronic Databases 
Combination of searches 
with 3 concepts:- 
Concept 1 – 
PSYCHOTHERAPY 
(includes all sub-types 
of therapy) 
AND 
Concept 2 – 
SCHIZOPHRENIA 
(includes psychosis) 
AND 
Concept 3 – 
ACUTE/INPATIENT 
psychiatric setting  
PsychINFO Keyword searches:- 
 brief psychotherapy 
 hospital admission 
 psychiatric hospital admission 
 psychiatric hospitalization 
 psychiatric hospitals 
 psychiatric units 
 psychotherapy 
 schizophrenia 
(.tw.) qualifier used to search following terms in title and/or 
abstract:- 
 acute 
 hospita* 
 inpatient? 
 psychosis 
 psychotic 
 psychoses 
 schizo* 
 therap* 
PubMed ((inpatient) AND psychosis) AND (psychotherapy OR therapy) 
EThOS 
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2. Theses/Dissertations ProQuest (any word)=psychosis OR schizophrenia AND (acute OR 
inpatient) 
3. Professional Body 
Publication 
Clinical Psychology 
Forum 
Hand-searched 
4. Conference 
abstracts 
Conference 
Proceedings 
Citation Index - 
Science (CPCI-S) 
 
(Topic Heading=(psychosis OR psychotic OR schizo*) AND 
TS=(acute OR hospita* OR inpatient*) AND TS=therap*) 
 
5. Trial Registries ISRCTN registry Condition=psychosis OR schizophrenia 
Inclusion criteria=inpatient OR acute 
Interventions=therapy OR behavioral Clinicaltrials.gov 
Cochrane Central 
Register of 
Controlled Trials  
6. Existing Reviews Cochrane Library TOPIC=mental health OR schizophrenia/psychosis AND 
therapy 
7. Grey Literature Trip Database (Area of Clinical Practice = Medicine OR Psychology OR 
Psychiatry OR Mental Health) AND (Psychotherapy OR 
Psychological therapies) AND (Inpatient OR Hospital) Open Gray 
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Studies included in review (with quality assessment) 
For ease of interpretation, MMAT scores are colour-coded with low quality scores (0%-25%) in red, a medium score (50%) in orange and high 
scores (75%-100%) in green. 
RANDOMISED CONTROLLED TRIALS (N=21) 
No. Author 
(year) 
 
n=total no. of 
participants 
 
Country 
Study 
Design 
(Record  
type) 
Therapy Model  
(Sub-type) 
Mode of 
Delivery 
Outcome  
Data 
Reported? 
MMAT 
Section 
assessed 
under 
MMAT  
score 
1 Kanas et al. 
(1980) (1) 
 
n=86 
 
USA 
RCT2 
(JA)3 
Non-CBT4 
(Psychodynamic) 
Group Yes 2. RCT 0% 
2 Beutler (1984) 
(2) 
 
n=176 
 
USA 
RCT 
(JA) 
CBT Group Yes 2. RCT 25% 
3 Cholet (1984) 
(3) 
 
n=40 
 
USA 
RCT 
(Thesis) 
Non-CBT 
(Humanistic- 
Existential) 
Individual Yes 2. RCT 50% 
4 Glick et al 
(1985) (4) 
 
n=144 
 
USA 
RCT 
(JA) 
CBT 
(Family 
Intervention) 
Family  Yes 2. RCT 50% 
                                                 
2 RCT=Randomised Controlled Trial 
3 JA=Journal article 
4 CBT=Cognitive-Behavioural Therapy 
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5 Youssef 
(1987) (5) 
 
n=30 
 
USA 
RCT 
(JA) 
Non-CBT 
(Psychoeducation 
only) 
Family Yes 2. RCT 0% 
6 Drury et al 
(1996) (6) 
 
n=62 
 
UK 
RCT 
(JA) 
CBT Individual 
+ Group  
+ Family 
Yes 2. RCT 0% 
7 Wahass and 
Kent (1997) 
(7) 
 
n=6 
 
Saudi Arabia 
RCT 
(JA) 
CBT 
(Culturally 
adapted) 
Individual Yes – but 
failed MMAT 
screening 
stage 
 
8 Haddock et al 
(1999) (8) 
 
n=21 
 
UK 
RCT 
(JA) 
CBT Individual Yes 2. RCT 25% 
9 Bach and 
Hayes (2002) 
 (9) 
n=80 
 
USA 
RCT 
(JA) 
CBT 
(Third-wave) 
Individual Yes 2. RCT 50% 
10 Lewis et al 
(2002) (10) 
 
n=309 
 
UK 
RCT 
(JA) 
CBT Individual Yes 2. RCT 100% 
11 Hall and 
Tarrier 
(2003) (11) 
 
n=25 
 
RCT 
(JA) 
CBT Individual Yes 2. RCT 100% 
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UK 
12 Bechdolf et al 
(2004) (12) 
 
n=88 
 
Germany 
RCT 
(JA) 
CBT Group Yes 2. RCT 100% 
13 Startup et al 
(2004) (13) 
 
n=90 
 
UK 
RCT 
(JA) 
CBT Individual Yes 2. RCT 25% 
14 Gaudiano 
and Herbert 
(2006) (14) 
 
n=40 
 
USA 
RCT 
(JA) 
CBT 
(Third-wave) 
Individual Yes 2. RCT 50% 
15 Klingberg et 
al (2010) (15) 
 
n=169 
 
Germany 
RCT 
(JA) 
CBT Individual 
+ Group  
+ Family 
Yes 2. RCT 50% 
16 Moritz et al 
(2011) (16) 
 
n=48 
 
Germany 
RCT 
(JA) 
CBT Individual 
+ Group  
Yes 2. RCT 100% 
17 Boden (2013) 
(17) 
 
n=18 
 
USA 
RCT 
(TR)5 
CBT 
(Third-wave) 
Individual Yes 2. RCT 0% 
18 Gaudiano 
(2015) (18) 
RCT 
(TR) 
CBT 
(Third-wave) 
Individual No (trial 
protocol only) 
 
                                                 
5 TR=Trial Registry 
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n=60 (target) 
 
USA 
19  Habib et al 
(2015) (19) 
 
n=42 
 
Pakistan 
RCT 
(JA) 
CBT 
(Culturally 
adapted) 
Individual Yes 2. RCT 50% 
20 Jacobsen et al 
(2016) (20) 
 
n=60 (target) 
 
UK 
RCT 
(JA) 
CBT (Third-wave) Individual No (trial 
protocol only) 
 
21 Tyrberg et al 
(2016) (21) 
 
n=21 
 
Sweden 
RCT 
(JA) 
CBT (Third-wave) Individual Yes 2. RCT 75% 
NON-RANDOMISED CONTROLLED TRIALS (N=14) 
No. Author 
(year) 
 
n=total no. of 
participants 
 
Country 
Study 
Design 
(Record  
type) 
Therapy Model  
(Sub-type) 
Mode of 
Delivery 
Outcome  
Data 
Reported? 
MMAT 
Section 
assessed 
under 
MMAT  
score 
1 Feifel and 
Schwartz 
(1953) (22) 
 
n=68 
 
USA 
Non-
randomised 
CT6 
(JA) 
Non-CBT 
(Psychodynamic) 
Group Yes 3. QNR7 50% 
                                                 
6 CT=Controlled Trial 
7 QNR=Quantitative Non-Randomised 
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2 Walker and 
Kelley (1960) 
(23) 
 
n=82 
 
USA 
Non-
randomised 
CT 
(JA) 
Non-CBT 
(Psychodynamic) 
Individual Yes 3. QNR 25% 
3 Bookhammer 
et al (1966) 
(24) 
 
n=51 
 
USA 
Non-
randomised 
CT 
(JA) 
Non-CBT 
(Psychodynamic) 
Unclear Yes 3. QNR 0% 
4 Stern et al 
(1972) (25) 
 
n=75 
 
USA 
Non-
randomised 
CT 
(JA) 
Non-CBT 
(Psychodynamic) 
Individual Yes 3. QNR 50% 
5 Gould et al 
(1975) (26) 
 
n=17 
 
USA 
Non-
randomised 
CT 
(JA) 
Non-CBT 
(Psychodynamic) 
Group Yes 3. QNR 75% 
6 Serok and 
Zemet (1983) 
(27) 
 
n=31 
 
Israel 
Non-
randomised 
CT 
(JA) 
Non-CBT 
(Gestalt) 
Group Yes 3. QNR 75% 
7 Levene et al 
(1989) (28) 
 
n=10 
 
Canada 
Non-
randomised 
CT 
(JA) 
Non-CBT 
(Family Therapy) 
Family Yes 3. QNR 25% 
8 Hodel et al 
(1998) (29) 
 
n=19 
Non-
randomised 
CT 
(JA) 
CBT 
(Emotional 
Management 
Therapy) 
Individual Yes 3. QNR 75% 
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Switzerland 
9 Hauff et al 
(2002) (30) 
 
n=96 
 
Norway 
Non-
randomised 
CT 
(JA) 
Non-CBT 
(Psychodynamic) 
Individual Yes 3. QNR 50% 
10 Veltro et al 
(2006) (31) 
 
n=502 
 
Italy 
Non-
randomised 
CT 
(JA) 
CBT Group Yes 3. QNR 0% 
11 Schmid and 
Wanderer 
(2007) (32) 
 
n=320 
 
Switzerland 
Non-
randomised 
CT 
(JA) 
Non-CBT 
(Phantasy therapy) 
Group Yes – but 
failed MMAT 
screening 
stage 
 
12 Mortan et al 
(2011) (33) 
 
n=12 
 
Turkey 
Non-
randomised 
CT 
(JA) 
CBT Group Yes 3. QNR 50% 
13 Owen et al 
(2015) (34) 
 
n=112 
 
UK 
Non-
randomised 
CT 
(JA) 
CBT 
(Third-wave) 
Group Yes 5. MM 50% 
14 Witkowska 
(2015) (35) 
 
n=60 
 
Poland 
Non-
randomised 
CT 
(JA) 
Non-CBT 
(Psychoeducation 
only) 
Individual Yes – but 
failed MMAT 
screening 
stage 
 
SERVICE EVALUATION (N=18) 
No. Author 
(year) 
Study 
Design 
Therapy Model  
(Sub-type) 
Mode of 
Delivery 
Outcome  
Data 
MMAT MMAT  
score 
34 
 
 
n=total no. of 
participants 
 
Country 
(Record  
type) 
Reported? Section 
assessed 
under 
1 Coffey (1954) 
(36) 
 
n=not stated 
 
USA 
Service 
Evaluation 
(BC)8 
Non-CBT 
(Psychodynamic) 
Group No  
2 Goldberg et 
al (1955) (37) 
 
n=not stated 
 
USA 
Service 
Evaluation 
(JA) 
Non-CBT 
(Psychodynamic) 
Group No  
3 Canter (1956) 
(38) 
 
n=60 
 
USA 
Service 
Evaluation 
(JA) 
Non-CBT 
(Psychodynamic) 
Group No 
 
 
4 Chazan 
(1974) (39) 
 
n=not stated 
 
Israel 
Service 
Evaluation 
(JA) 
Non-CBT 
(Psychodynamic) 
Family 
(Group) 
No 
 
 
5 Birckhead 
(1984) (40) 
 
n=not stated 
 
USA 
Service 
Evaluation 
(JA) 
Non-CBT 
(Psychodynamic) 
Group No 
 
 
6 Cole and 
Greene 
(1988) (41) 
 
n=20 
Service 
Evaluation 
(JA) 
Non-CBT 
(Psychodynamic) 
Group Yes 4. QD9 0% 
                                                 
8 BC= Book chapter 
9 QD= Quantitative Descriptive 
35 
 
 
USA 
7 Kelly et al 
(1990) (42) 
 
n=not stated 
 
UK 
Service 
Evaluation 
(JA) 
Non-CBT 
(Supportive 
Counselling) 
Group No  
8 Aviera (1996) 
(43) 
 
n=not stated 
 
USA 
Service 
Evaluation 
(JA) 
No clear therapy 
model 
Group No  
9 Linszen et al 
(1998) (44) 
 
n=76 
 
Netherlands 
Service 
Evaluation 
(JA) 
CBT 
(Family 
Intervention) 
Family Yes – but 
failed MMAT 
screening 
stage 
 
10 Dodd and 
Wellman 
(2000) (45) 
 
n=23 
 
UK 
Service 
Evaluation 
(JA) 
CBT Group Yes – but 
failed MMAT 
screening 
stage 
 
11 Fell and Sams 
(2004) (46) 
 
n=91 
 
UK 
Service 
Evaluation 
(JA) 
CBT Group Yes – but 
failed MMAT 
screening 
stage 
 
12 Durrant et al 
(2007) (47) 
 
n=14 
 
UK 
Service 
Evaluation 
(JA) 
CBT 
(Third-wave) 
Individual Yes 4. QD 50% 
13 Tickle et al 
(2009) (48) 
 
n=not stated 
Service 
Evaluation 
(JA) 
CBT Group Yes – but 
failed MMAT 
screening 
stage 
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UK 
14 Lynch et al 
(2011) (49) 
 
n=78 
 
USA 
Service 
Evaluation 
(JA) 
CBT Individual 
+ Group 
Yes 4. QD 75% 
15 Raune and 
Daddi (2011) 
(50) 
 
n=137 
 
UK 
Service 
Evaluation 
(JA) 
CBT Group Yes 4. QD 75% 
16 Steiner and 
Harland 
(2011) (51) 
 
n=not stated 
 
UK 
Service 
Evaluation 
(JA) 
Non-CBT 
(Psychodynamic) 
Group No  
17 Heriot-
Maitland et al 
(2014) (52) 
 
n=not stated 
 
UK 
Service 
Evaluation 
(JA) 
CBT 
(Third-wave) 
Group Yes 5. MM10 75% 
18 Nikolitch et al 
(2016) (53) 
 
n=40 
 
Canada 
Service 
Evaluation 
(JA) 
CBT 
(Third-wave) 
Group Yes 4. QD 75% 
CASE SERIES (N=5) 
No. Author 
(year) 
 
Study 
Design 
(Record  
type) 
Therapy Model  
(Sub-type) 
Mode of 
Delivery 
Outcome  
Data 
Reported? 
MMAT 
Section 
assessed 
under 
MMAT  
score 
                                                 
10 MM= Mixed Methods 
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n=total no. of 
participants 
 
Country 
1 Boyd (1979) 
(54) 
 
n=3 
 
USA 
Case Series 
(JA) 
Non-CBT 
(Psychodynamic) 
Individual 
+ Group 
No 
 
 
2 Cole 
(1993) (55) 
 
n=3 
 
USA 
Case Series 
(BC) 
CBT 
(Family 
Intervention) 
Family No  
3 Ahmed et al 
(1997) (56) 
 
n=3 
 
USA 
Case Series 
(JA) 
No clear therapy 
model 
Individual Yes – but 
failed MMAT 
screening 
stage 
 
4 Kerr (2001) 
(57) 
 
n=4 
 
UK 
Case Series 
(JA) 
Non-CBT 
(CAT)11 
Individual No  
5 Freemantle 
and Clarke 
(2009) (58) 
 
n=2 
 
UK 
Case Series 
(BC) 
CBT 
(Third-wave) 
Individual No  
SINGLE CASE STUDIES (N=4) 
No. Author 
(year) 
 
Study 
Design 
(Record  
type) 
Therapy Model  
(Sub-type) 
Mode of 
Delivery 
Outcome  
Data 
Reported? 
MMAT 
Section 
assessed 
under 
MMAT  
score 
                                                 
11 CAT= Cognitive-Analytical Therapy 
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n=total no. of 
participants 
 
 
Country 
1 Dublin (1973) 
(59) 
 
n=1  
 
USA 
Case Study 
(JA) 
Non-CBT 
(Gestalt) 
Individual No  
2 Ginsburg 
(2000) (60) 
 
n=1  
 
USA 
Case Study 
(JA) 
Non-CBT 
(Supportive 
Counselling) 
Individual No  
3 Mansell and 
Fadden 
(2009) (61) 
n=1  
 
UK 
Case Study 
(BC) 
CBT 
(Family 
Intervention) 
Family No  
4 Cooper (2014) 
(62) 
 
n=1  
 
UK 
Case Study 
(JA) 
Non-CBT 
(Psychodynamic) 
Group Yes – but 
failed MMAT 
screening 
stage 
 
QUALITATIVE ONLY (N=3) 
No. Author 
(year) 
 
n=total no. of 
participants 
 
Country 
Study 
Design 
(Record  
type) 
Therapy Model  
(Sub-type) 
Mode of 
Delivery 
Outcome  
Data 
Reported? 
MMAT 
Section 
assessed 
under 
MMAT  
score 
1 Holma and 
Aaltonen 
(1997) (63) 
 
n=15 
Qualitative 
(JA) 
Non-CBT 
(Family Therapy) 
Family Qualitative 
data only 
1. Qual 50% 
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Finland 
2 Gonzalez de 
Chavez et al 
(2000) (64) 
 
n=32 
 
Spain 
Qualitative 
(JA) 
Non-CBT 
(Psychodynamic) 
Group Qualitative 
data only 
1. Qual 75% 
3 York (2007) 
(65) 
 
n=8 
 
UK 
Qualitative 
(JA) 
CBT 
(Third-wave) 
Group Qualitative 
data only 
1. Qual 75% 
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Risk of bias summary for RCTs only using Cochrane Tool 
 
 
Selection Bias Performance 
Bias 
Detection 
Bias 
Attrition 
Bias 
Reporting 
Bias 
Other 
Bias 
Random 
sequence 
generation 
Allocation 
concealment 
Blinding 
(participants 
and 
personnel) 
Blinding 
of 
outcome 
assessment 
Incomplete 
outcome 
data 
Selective 
reporting 
1 Kanas et 
al.(21) 
 
USA 
      No ITT 
analysis 
2 Beutler (22) 
 
USA 
      No ITT analysis 
3 Cholet (14) 
 
USA 
      Unclear 
if ITT 
analysis 
Small N 
(N=20 in 
treatment 
arm) 
4 Glick, 
Clarkin 
(23) 
 
USA 
      Unclear 
if ITT 
analysis 
 
5 Youssef 
(24) 
 
USA 
      No ITT 
Analysis 
Small N 
(N=15 in 
treatment 
arm) 
6 Drury, 
Birchwood 
(25) 
 
UK 
      No ITT 
analysis 
7 Wahass and 
Kent (26) 
 
      Small N 
(N=3 in 
treatment 
arm) 
    
  
  
  
    
    
   
 
  
  
      
  
  
  
  
  
41 
 
Saudi 
Arabia 
8 Haddock, 
Tarrier (27) 
 
UK 
      Unclear 
if ITT 
analysis 
Small N 
(N=10 in 
treatment 
arm) 
9 Bach and 
Hayes (28) 
 
USA 
      No ITT 
analysis 
10 Lewis, 
Tarrier (20) 
 
UK 
      None 
11 Hall and 
Tarrier (29) 
 
UK 
      No ITT 
Analysis 
Small N 
(N=12 in 
treatment 
arm) 
12 Bechdolf, 
Knost (30) 
 
Germany 
      None 
13 Startup, 
Jackson 
(31) 
 
UK 
      None 
14 Gaudiano 
and 
Herbert 
(32) 
 
USA 
      Small N 
(N=19 in 
treatment 
arm) 
15 Klingberg, 
Wittorf (33) 
 
Germany 
      Unclear 
if ITT 
analysis 
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16 Moritz, 
Veckenstedt 
(34) 
 
Germany 
      Small N 
(N=24 in 
treatment 
arm) 
17 Boden (16) 
 
USA 
      Unclear 
if ITT 
analysis 
Small N 
(N=12 in 
treatment 
arm) 
18 Gaudiano 
(15) 
 
USA 
NOT ASSESSED – TRIAL PROTOCOL ONLY 
19 Habib, 
Dawood 
(35) 
 
Pakistan 
      No ITT 
analysis 
Small N 
(N=21 in 
treatment 
arm) 
20 Jacobsen, 
Peters (36) 
 
UK 
NOT ASSESSED – TRIAL PROTOCOL ONLY 
21 Tyrberg, 
Carlbring 
(37) 
 
Sweden 
      Small N 
(N=11 in 
treatment 
arm) 
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